← FDA Drug Approvals (Drugs@FDA)

RANITIDINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2018-11-23

Drug application

FDA Application #
ANDA210681
Application type
Abbreviated New Drug Application (Generic)
Brand name
RANITIDINE HYDROCHLORIDE
Generic name
Ranitidine Hydrochloride
Active ingredients
RANITIDINE HYDROCHLORIDE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Discontinued
Sponsor
NOVITIUM PHARMA
First approval
2018-11-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown